IFI27L1 is a gene involved in the interferon response, which helps cells react to viral infection and other immune signals. This gene plays an important role in helping cells adjust to inflammation and cell stress. If the IFI27L1 gene does not work as expected, these defenses may be less well controlled, which can affect how tissues respond to infection or damage. It is mainly discussed in medical research rather than public culture.
What is a gene?
A gene is a piece of DNA that holds instructions your cells use to make molecules or regulate processes in the body. Some genes carry the information needed to produce proteins, the parts of cells that do the work. Other genes mainly direct when certain processes happen, where they happen, and how active they are. Together, genes shape how the body develops and works, and they can influence how you respond to food, stress, or medications. To go into this topic in more detail, you can find more in the LearnHub.
Overview
IFI27L1Gene function
What if the gene works
The IFI27L1 gene helps cells respond to interferon signals during viral defense. It is part of the body’s early immune response and may influence how cells handle inflammation and stress.
Risk
What if the gene does not work
Milder to more severe variants in the IFI27L1 gene can reduce or alter this interferon responsive protein, which may change how strongly some cells react to immune signaling. This mainly affects cellular stress and antiviral response pathways.
Treatment
What does that mean for your treatment
No IFI27L1-specific treatment or management approach is currently established for people with a pathogenic or loss-of-function variant in the IFI27L1 gene.
Gene function
What if the gene works
Your cells use the IFI27L1 gene to react to interferon, one of the body’s early immune alarm signals. When this gene is switched on, cells shift into a more protective state, especially during viral infections. It supports normal immune activity and balanced responses to cell stress.
The IFI27L1 gene is one of the genes cells switch on after interferon signals arrive. This helps cells respond to interferon during viral infections and prepare to limit viral spread.
The protein made from the IFI27L1 gene helps cells adjust to immune related stress inside the cell. In normal function, this supports orderly cell behavior and controlled turnover of cells that have been heavily strained.
What is a variant?
A genetic variant is a slight difference in the DNA sequence within a gene. These differences are common and form part of normal human diversity, such as differences in appearance, metabolism, or the way the body responds to environmental influences. Many have no noticeable effect and simply reflect natural genetic variation. In some situations, however, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Changes in the IFI27L1 gene can alter how much IFI27L1 protein a cell makes or how stable that protein is after it is produced. Among IFI27L1 gene variants, milder changes may slightly affect protein folding, its location in the cell, or how it interacts with partner proteins, while more severe variants can disrupt RNA splicing (how the cell edits the gene message) or create a shortened protein with little or no activity. These effects can vary from one variant to another.
How variants are linked to conditions
Current evidence does not yet show a broadly confirmed link between variants of the IFI27L1 gene and one specific health condition, though research on how IFI27L1 gene variants are linked to conditions may evolve over time. Anyone with a confirmed finding involving the IFI27L1 gene should rely on guidance from their doctor or genetic counselor for interpretation in the context of their own health and family history.
A variant is not necessarily a diagnosis
Gene variants are a routine part of human biology and are widespread in the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, however, a single well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There isn't yet broadly confirmed evidence on specific factors that increase or reduce health risk related to IFI27L1. If you have concerns about your personal or family risk, a doctor or genetic counselor can help put genetic results in context.
Inheritance of IFI27L1 variants
There is not yet a broadly confirmed disease inheritance pattern for the IFI27L1 gene, so how IFI27L1 variants are inherited in relation to a specific health condition is still being worked out. The IFI27L1 gene is located on an autosome, which means you inherit one copy from each parent.
What does my IFI27L1 result mean for my family?
There is not yet a broadly confirmed inheritance pattern tied to a specific health condition for the IFI27L1 gene, though this can change as research grows. If you have a specific IFI27L1 result and want to understand what it could mean for your relatives, a doctor or genetic counselor can explain it in the context of your family history and the exact finding.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry an IFI27L1 variant, IFI27L1 genetic testing reads DNA from a blood, saliva, or cheek swab sample. This may be done as part of a multigene panel, exome sequencing, or genome sequencing, and results help classify a change as benign, likely benign, uncertain, or clinically relevant.
When should I consider getting a genetic test?
There isn't yet a broadly established, IFI27L1-specific clinical reason for genetic testing. Decisions about testing are best made with a doctor or genetic counselor, based on your personal health history, family history, and the reason testing is being considered.
A genetic result is only one part of your health story
A genetic finding can provide useful insight, yet how informative it is varies with the condition and the kind of variant identified. Over time, factors including lifestyle, environment, age, and medical history also influence how the body functions. For some conditions, particularly those shaped by many genes, genetic information offers context rather than certainty and makes the most sense when viewed with the rest of a person’s care. In other situations, a genetic result can give a clear answer. In fields like medication response, genetic results may help put personal experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body absorbs, breaks down, or responds to a drug, so the same treatment may work better for one person than for another. These differences are common and can influence how much benefit someone gets from a medicine or how sensitive they are to side effects.
What is Pharmacogenetics?
Pharmacogenetics is the area of study focused on how genetic differences affect a person’s response to medications. It examines links between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes can influence both how strongly a drug works and how the body processes it. This information can support more informed and more individualized treatment decisions. If you want to read more about this topic, you can learn more in the LearnHub.
Drugs influenced by the IFI27L1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or response, so questions about side effects, new symptoms, or whether a treatment is right for you are best discussed with your doctor.
History
In recent decades, awareness of the IFI27L1 gene’s role has grown through broader research on genes that switch on during immune signaling. It was identified as part of a larger group of related genes uncovered as scientists mapped human gene activity in more detail. From these first observations, research expanded steadily, and IFI27L1 later appeared in studies looking at gene activity patterns in cancer and inflammatory conditions. Over time, descriptions became more precise as sequencing tools improved and researchers could compare it more carefully with closely related genes. The way this gene was viewed has shifted over time, moving from a newly cataloged gene to one of interest in studies of immune and disease related gene signatures.